GlaxoSmithKline has decided to stop paying physicians to promote its products and to cease tying sales-representative compensation to the number of prescriptions physicians write. (posted Feb. 14)
Do Women Receive Worse Gout Treatment Than Men?
Women with gout are more likely to have contraindications to nonsteroidal antiinflammatory drugs and are less likely to receive urate-lowering drugs than men with the disease. (posted Feb. 5)
Interleukin 1-alpha Is Critical for Establishment of Inflammatory Lung Disease
New research clarifies the role of fibroblasts in chronic lung disease. (posted Jan. 21)
Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?
Long-term use of TNFα inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis is associated with both gains in fat mass and a shift in fat mass to the visceral region. (posted Jan. 14)
Joint Smart Coalition Takes on Psoriasis in New York City
The Arthritis Foundation and the National Psoriasis Foundation launched the Joint Smart Coalition to focus on patient education, resources, and outreach. At a coalition-sponsored community-outreach event at Queens College in Flushing, N.Y., attendees were provided information on setting goals, stretching techniques, easy exercises, treatment options, and tips for a healthy lifestyle. (posted Dec. 13)
Event Honors Lupus Patients
The Hospital for Special Surgery Division of Rheumatology held an event “Honoring Lupus Heroes” as part of its 150th anniversary celebration. (posted Nov. 26)
The American College of Rheumatology Helps Keep Three Biologics Off the SAD List
In October, the Centers for Medicare and Medicaid Services directed carriers to again include three biologics in Medicare Part B coverage. (posted Nov. 19)
Genetic Link Between Cellular Cholesterol Homeostasis and Energy Metabolism
A new study suggests that GATM may serve as the functional link between the ability of statins to lower cholesterol and their ability to cause statin-induced myopathy. (posted Nov. 19)
Colchicine Effective for Acute Pericarditis
Patients with acute pericarditis who are treated with colchicine in combination with a traditional antiinflammatory therapy experience a significantly reduced rate of incessant or recurrent pericarditis. (posted Oct. 31)
Survey Highlights High Out-of-pocket Costs for RA Care
The “RA in America 2013″ survey estimates out-of-pocket cost for RA treatment at $1,000 to $5,000 per year. (posted Oct. 25)
- « Previous Page
- 1
- …
- 308
- 309
- 310
- 311
- 312
- …
- 319
- Next Page »